C/sub 6/H/sub 5/CH/sub 3/
Aptamer-functionalized peptide H<sub>3</sub>CR<sub>5</sub>C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
15
The Molecular Structure and Spectral Characteristics of Heavy Metal Chelating Agent of H<sub>3</sub>TMT and Its Complex (HgMe)<sub>3</sub>TMT with CH<sub>3</sub>HgCl - Volume 6 Number 3 (Jun. 2015) - IJCEA
5
Retrospective analysis of a lactose breath test in a gastrointestinal symptomatic population of Northeast Italy: use of (H<sub>2</sub>+2CH<sub>4</sub>) versus H<sub>2</sub> threshold
6
Anticonvulsant effects of isomeric nonimidazole histamine H<sub>3</sub> receptor antagonists
19
Decreased bacteria activity on Si<sub>3</sub>N<sub>4</sub> surfaces compared with PEEK or titanium
12
Preclinical studies of N<sub>3</sub>-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H<sub>22</sub>-bearing mice
11
H<sub>2</sub> Sensor Based on Au/TiO<sub>2</sub> Nanoparticles by Flame Made
8
Drug-likeness approach of 2-aminopyrimidines as histamine H<sub>3</sub> receptor ligands
15
Technical Evaluation of C<sub>3</sub>-MR and Cascade Cycle on Natural Gas Liquefaction Process - Volume 5 Number 6 (Dec. 2014) - IJCEA
6
CaCO<sub>3</sub>/CaIP<sub>6</sub> composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growth
12
Binding fullerenol C<sub>60</sub>(OH)<sub>24</sub> to dsDNA
7
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
10
Effects of an oral dose of l-glutamic acid on circulating neurotransmitters: Possible roles of the C<sub>1</sub>(Ad) and the A<sub>5</sub>(NA) pontomedullary nuclei
7
Gd<sub>2</sub>O<sub>3</sub> nanoparticles in hematopoietic cells for MRI contrast enhancement
8
Cut-off value of FEV<sub>1</sub>/FEV<sub>6</sub> as a surrogate for FEV<sub>1</sub>/FVC for detecting airway obstruction in a Korean population
7
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
11
Sub-10 nm Cu<sub>5</sub>FeS<sub>4</sub> cube for magnetic resonance imaging-guided photothermal therapy of cancer
10
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
15
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
6